COMMUNIQUÉS West-GlobeNewswire

Arch Biopartners Announces Appointment of Dr. Patrick Vink as Chairman of the Board
16/01/2026
TORONTO, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc . (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today the appointment of Dr. Patrick Vink as Chairman of the Company’s Board of [...]
Clene to Present at the Emerging Growth Conference
16/01/2026
SALT LAKE CITY, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company [...]
Palisade Bio Announces Two Abstracts Selected for Poster Presentations at Leading Global Inflammatory Bowel Disease Conferences
16/01/2026
PALI-2108 Abstracts Highlight Gut-Targeted PDE4B Inhibition and Translational Phase 1a Findings in Ulcerative Colitis Carlsbad, CA, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the [...]
SRx Health Solutions Invests in Common Stock of Opendoor Technologies
16/01/2026
NORTH PALM BEACH, Fla., Jan. 16, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") today announced that it has invested in the common stock of Opendoor Technologies Inc., a [...]
Glow Holdings, Inc. Introduces GlohCo as Its Healthtech Intelligence Platform
16/01/2026
HOUSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Glow Holdings, Inc. (OTC: GLOH), doing business as GlohCo, today announced its transition into a healthtech-focused public company following a corporate reset completed in 2025 [...]
OneMedNet Delivers a Real-World Data feed of 1.5M Patients consisting of 4M encounters
16/01/2026
MINNEAPOLIS, Jan. 16, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced that this month it has successfully delivered [...]
Baylor Genetics Supports Bipartisan House Bill to Broaden Medicaid Access to Genomic Sequencing for Children who Meet Medical Criteria
16/01/2026
Company joins forces with Genomic Answers for Children’s Health Alliance to clarify genomic sequencing as covered under Medicaid’s “Early and Periodic Screening, Diagnostic, and Treatment Services” HOUSTON, Jan. 16, [...]
Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million
16/01/2026
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody [...]
Sharps Technology Strengthens Market Confidence with Advisor Lock-Up Agreement
16/01/2026
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) today announced that it has entered into a 90-day lock-up agreement with SOL Markets (the “Strategic Advisor”), pursuant to which SOL [...]
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/01/2026
WATERTOWN, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, [...]
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation
16/01/2026
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- AtaiBeckley Inc. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biotechnology company on a mission to transform patient outcomes by developing rapid-acting, [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date
16/01/2026
WILMINGTON, Del., Jan. 16, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) (the “Company”), a clinical-stage biopharmaceutical company, today announced that it will hold its annual meeting of [...]
Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue
16/01/2026
Research-use-only offerings are commercially available, enabling immediate product and service revenue generation Targets the global CRO market of $47.9 billion in 2025 and growing at 7% CAGR BERKELEY, Calif, Jan. 16, [...]
Onco360® Has Been Selected as the National Pharmacy Partner for UNLOXCYT™ (cosibelimab-ipdl)
16/01/2026
LOUISVILLE, K.Y., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent Specialty Pharmacy, has been selected as the national pharmacy partner by Sun Pharmaceuticals for UNLOXCYT ™ (cosibelimab- [...]
Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator (PNS) System as the Only Full-Body PNS Therapy Available in the United States for Craniofacial Pain
16/01/2026
POMPANO BEACH, Fla., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the commercial availability of the Freedom ® PNS System for [...]
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds
16/01/2026
LITTLETON, Colo., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (Nasdaq: VVOS), a leading medical device and healthcare services company focused on sleep related breathing [...]
Extendicare Announces Timing of 2025 Fourth Quarter Results and Conference Call
16/01/2026
MARKHAM, Ontario, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter of 2025 after market [...]
Elicio Therapeutics Reports Inducement Grants
16/01/2026
BOSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio” or the “Company”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of [...]
QHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of Growth
16/01/2026
Governance evolution follows elimination of major convertible debt, recent funding, and improved capital structure Company advances governance framework aligned with shareholder interests and future listing requirements [...]

Pages